|
|||||
|
|
Subcutaneous trastuzumab with pertuzumab and docetaxel in HER2-positive metastatic breast cancer: Final analysis of MetaPHER,a phase IIIb single-arm safety study |
|
| Authors: | Kuemmel Sherko Tondini Carlo A Abraham Jacinta Nowecki Zbigniew Itrych Bartosz Hitre Erika Karaszewska Bogusława Juárez-Ramiro Alejandro Morales-Vásquez Flavia Pérez-García Jose Manuel Cardona-Huerta Servando Monturus Estefania Sequi Marco Restuccia Eleonora Benyunes Mark Martín Miguel |
| Affiliation: | 1.Breast Unit, Kliniken Essen-Mitte, Henricistrasse 92, 45136, Essen, Germany ;2.Clinic for Gynecology With Breast Center, Charité–Universit?tsmedizin Berlin, Berlin, Germany ;3.Department of Onco-Hematology, ASST Papa Giovanni XXIII, Bergamo, Italy ;4.Department of Clinical Oncology, Velindre Cancer Centre, Cardiff, UK ;5.Klinika Nowotworów Piersi i Chirurgii Rekonstrukcyjnej, Centrum Onkologii-Instytut, Warsaw, Poland ;6.Department of Oncology, Magodent, Warsaw, Poland ;7.Department of Medical Oncology and Clinical Pharmacology “B”, National Institute of Oncology, Budapest, Hungary ;8.Przychodnia Lekarska KOMED, Konin, Poland ;9.Medical Oncology, CME Consultorio de Medicina Especializada, Mexico City, Mexico ;10.FUCAM, Instituto Nacional de Cancerología de Mexico, Mexico City, Mexico ;11.Medical Oncology Department, Vall D′Hebron Institute of Oncology (VHIO), Hospital Universitari Vall D’Hebron, Barcelona, Spain ;12.Centro de Cáncer de Mama, Hospital Zambrano-Hellion, Tecnológico de Monterrey, Monterrey, Mexico ;13.Product Development Oncology, F. Hoffmann-La Roche Ltd, Basel, Switzerland ;14.Biostatistics, F. Hoffmann-La Roche Ltd, Basel, Switzerland ;16.Product Development Oncology, Genentech, Inc., South San Francisco, CA, USA ;17.Departamento de Medicina, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Gregorio Mara?ón, CIBERONC, Madrid, Spain ; |
| Abstract: | Breast Cancer Research and Treatment - Intravenous trastuzumab, pertuzumab, and docetaxel are first-line standard of care for patients with HER2-positive metastatic breast cancer (mBC). MetaPHER is... |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |
